Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Thyroid Associated Orbitopathy”

30 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 30 results

Testing effectiveness (Phase 2)Study completedNCT03110848
What this trial is testing

Effects of Atorvastatin in Graves' Orbitopathy (GO)

Who this might be right for
Thyroid Associated OphthalmopathyHypercholesterolemia
University of Pisa 88
Large-scale testing (Phase 3)Looking for participantsNCT06112340
What this trial is testing

Extension Study of Two Doses of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED)

Who this might be right for
Thyroid Eye DiseaseGraves OrbitopathyEndocrine System Diseases+9 more
Sling Therapeutics, Inc. 75
Testing effectiveness (Phase 2)Study completedNCT01727973
What this trial is testing

Efficacy of Subantimicrobial Dose Doxycycline for Moderate to Severe and Active Graves' Orbitopathy

Who this might be right for
Graves OphthalmopathyGraves DiseaseEye Diseases+6 more
Sun Yat-sen University 14
Not applicableApproved For MarketingNCT04040894
What this trial is testing

Expanded Access Protocol of Teprotumumab (HZN-001) for Patients With Active Thyroid Eye Disease

Who this might be right for
Thyroid Eye DiseaseGraves' Orbitopathy
Amgen
Large-scale testing (Phase 3)Looking for participantsNCT03131726
What this trial is testing

Treatment of Graves´ophthalmopathy with Simvastatin (GO-S)

Who this might be right for
Graves OphthalmopathyThyroid Associated OphthalmopathyThyroid Associated Orbitopathy
Lund University 80
Early research (Phase 1)Study completedNCT06674941
What this trial is testing

A Trial to Investigate Teprotumumab (High-concentration Formulation) Subcutaneous Administration in Healthy Adult Non-Japanese and Japanese Participants

Who this might be right for
Healthy Volunteers
Amgen 44
Large-scale testing (Phase 3)Study completedNCT06384547
What this trial is testing

A Randomized, Controlled, Safety and Tolerability Study of VRDN-001 in Participants With Thyroid Eye Disease (TED)

Who this might be right for
Thyroid Eye Disease
Viridian Therapeutics, Inc. 231
Large-scale testing (Phase 3)Active Not RecruitingNCT05276063
What this trial is testing

A Phase 2b, Study of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED)

Who this might be right for
Thyroid Eye DiseaseGraves OrbitopathyEndocrine System Diseases+9 more
Sling Therapeutics, Inc. 90
Large-scale testing (Phase 3)WithdrawnNCT02112643
What this trial is testing

Selenium in Mild Thyroid Eye Disease in North America

Who this might be right for
Thyroid Associated Ophthalmopathies
Columbia University
Large-scale testing (Phase 3)UnknownNCT01809444
What this trial is testing

Prednisone Versus Doxycycline in the Treatment of Graves' Orbitopathy

Who this might be right for
Thyroid Associated Opthalmopathies
Sun Yat-sen University 146
Not applicableStudy completedNCT03535090
What this trial is testing

Coagulation After Intravenous Methylprednisolone Administration

Who this might be right for
Graves' DiseaseGraves OphthalmopathyBlood Coagulation+1 more
Piotr Miskiewicz 26
Testing effectiveness (Phase 2)UnknownNCT02203682
What this trial is testing

Doxycycline Treatment in Mild Thyroid-Associated Ophthalmopathy

Who this might be right for
Graves OphthalmopathyGraves DiseaseThyroid-associated Ophthalmopathy+6 more
Sun Yat-sen University 100
Large-scale testing (Phase 3)Study completedNCT06021054
What this trial is testing

An Efficacy, Safety, and Tolerability Study of Veligrotug (VRDN-001), in Participants With Chronic Thyroid Eye Disease (TED) (THRIVE-2)

Who this might be right for
Thyroid Eye Disease
Viridian Therapeutics, Inc. 188
Testing effectiveness (Phase 2)Study completedNCT01868997
What this trial is testing

Teprotumumab (RV 001) Treatment in Patients With Active Thyroid Eye Disease

Who this might be right for
Thyroid Associated OphthalmopathiesThyroid-Associated Ophthalmopathy
Amgen 88
Large-scale testing (Phase 3)Active Not RecruitingNCT06625411
What this trial is testing

An Efficacy, Safety, and Tolerability Study of VRDN-003 in Participants With Active Thyroid Eye Disease (TED)

Who this might be right for
Thyroid Eye Disease
Viridian Therapeutics, Inc. 132
Testing effectiveness (Phase 2)Looking for participantsNCT04936854
What this trial is testing

Sirolimus vs Corticosteroids in Treatment of Thyroid Eye Disease

Who this might be right for
Thyroid-Associated Ophthalmopathy
Haukeland University Hospital 60
Early research (Phase 1)Study completedNCT06563856
What this trial is testing

TEPEZZA Subcutaneous Administration in Healthy Adults

Who this might be right for
BioavailabilityBioequivalence
Amgen 37
Large-scale testing (Phase 3)Study completedNCT06179875
What this trial is testing

An Open-label Study (OLE) for Non-responders of VRDN-001-101 and VRDN-001-301

Who this might be right for
Thyroid Eye Disease
Viridian Therapeutics, Inc. 143
Large-scale testing (Phase 3)Study completedNCT03298867
What this trial is testing

Treatment of Graves' Orbitopathy (Thyroid Eye Disease) to Reduce Proptosis With Teprotumumab Infusions in a Randomized, Placebo-Controlled, Clinical Study

Who this might be right for
Thyroid Eye DiseaseGraves' Orbitopathy
Amgen 83
Large-scale testing (Phase 3)Study completedNCT01297699
What this trial is testing

Tocilizumab Treatment in Graves´ Ophthalmopathy (Graves´ Orbitopathy or Thyroid Eye Disease)

Who this might be right for
Thyroid Associated OphthalmopathiesGraves´ OphthalmopathyThyroid Eye Disease
Hospital Clinico Universitario de Santiago 32
Load More Results